ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.106788A>T (p.Thr35596=)

gnomAD frequency: 0.00010  dbSNP: rs369896045
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000040982 SCV000064673 likely benign not specified 2012-04-05 criteria provided, single submitter clinical testing Thr33028Thr in exon 309 of TTN: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and it is not located within the splice consensus sequence. Thr33028Thr in exon 309 of TTN (allele f requency = n/a)
Invitae RCV000474394 SCV000555617 benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-22 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000040982 SCV000708780 likely benign not specified 2017-05-23 criteria provided, single submitter clinical testing
GeneDx RCV001540268 SCV001758134 likely benign not provided 2020-03-13 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839769 SCV002100421 benign Autosomal recessive limb-girdle muscular dystrophy type 2J 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839770 SCV002100432 benign Myopathy, myofibrillar, 9, with early respiratory failure 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839771 SCV002100443 benign Early-onset myopathy with fatal cardiomyopathy 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839768 SCV002100454 benign Tibial muscular dystrophy 2021-09-10 criteria provided, single submitter clinical testing
Ambry Genetics RCV002415482 SCV002677451 benign Cardiovascular phenotype 2020-07-21 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Clinical Genetics, Academic Medical Center RCV000040982 SCV001924789 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001540268 SCV001952398 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.